1.Clinical analysis of benign anastomotic stenosis after colorectal cancer surgery
Wei ZHENG ; Shurong HUANG ; Yong' ; an FU ; Hongyue LIN ; Jinping CHEN
China Modern Doctor 2024;62(9):62-65
Objective To analyze the influencing factors and management of benign anastomotic stenosis in patients with colorectal cancer after concurrent prophylactic ileostomy.Methods The clinical data of 74 colorectal cancer patients undergoing preventive ileostomy admitted to Quanzhou First Hospital Affiliated to Fujian Medical University from April 2018 to June 2022 were selected,according to the presence or absence of anastomotic stenosis after surgery,patients were divided into anastomotic stenosis group and anastomotic normal group.The influencing factors of stenosis were analyzed using statistical methods,and the management methods for anastomotic stenosis were summarized.Results 15 cases of anastomotic stenosis occurred after surgery,with an incidence rate of 20.3%.Compared with anastomotic normal group,patients in anastomotic stenosis group had a higher proportion of preoperative radiation therapy,preoperative neoadjuvant chemotherapy,and a higher incidence of postoperative anastomotic leakage/pelvic infection,with statistical significance(P<0.05);Multivariate analysis suggests that preoperative radiotherapy,anastomotic leakage/pelvic infection are independent risk factors for anastomotic stenosis.Conclusion Patients with colorectal cancer who undergo preoperative radiotherapy,neoadjuvant chemotherapy,and postoperative anastomotic leakage/pelvic infection should pay attention to the occurrence of anastomotic stenosis after undergoing ileostomy;Postoperative anastomotic stenosis should be treated according to the characteristics of the stenosis.
2.Regression analysis of risk factors related to coronary artery lesion in children with Kawasaki disease
Cuiping Qian ; Xiaobi Huang ; Sheng Zhao ; Yong Zhang
Acta Universitatis Medicinalis Anhui 2023;58(3):490-494
Objective :
To investigate risk factors related to coronary artery lesion( CAL) in children with Kawasaki disease.
Methods :
Retrospective analysis was conducted on clinical data of 144 children with Kawasaki disease. The cases were divided into two groups according to whether they had CAL or not.There were 50 children in CAL group and 94 children in non-coronary artery lesion(NCAL) group.The clinical and laboratory indicators in the two groups were analyzed and compared,and the diagnostic efficacy of these indicators for Kawasaki disease combined with CAL was analyzed by drawing the receiver operating characteristic (ROC) curve.
Results :
There was no statistical significant difference in age,gender,duration of fever,use time of immunoglobulin,erythrocyte sedimentation rate,C-reactive protein,serum amyloid A,N-terminal pro brain natriuretic peptide,white blood cell,hemoglobin and platelet between the two groups (P>0. 05) .In CAL group,the serum levels of 25-( OH) D3 and albumin were lower,while the levels of alanine transaminase,interleukin-6 and procalcitonin were higher than those in NCAL group (P<0. 05) .Multivariate logistic regression analysis showed that the levels of serum 25-( OH) D3 ( OR = 0. 984,95% CI:0. 974 ~0. 995) ,albumin ( OR = 0. 857,95% CI:0. 771-0. 951) ,alanine transaminase ( OR = 1. 011,95% CI : 1. 005 -1. 017) and interleukin-6 ( OR = 1. 002,95% CI : 1. 000 -1. 005 ) were significantly related with coronary artery lesion in children with kawasaki disease (P<0. 05) .The levels of 25-( OH) D3 ,albumin,alanine transaminase and interleukin-6 in serum had diagnostic value for Kawasaki disease combined with CAL,and the area under the curve (AUC) were 0. 660,0. 652,0. 711,and 0. 700,respectively.The AUC of combined diagnosis of four indicators was 0. 816 .
Conclution
Decrease of serum 25-( OH) D3 and albumin levels,increase of serum interleukin-6 and alanine transaminase levels in children with Kawasaki disease are risk factors for CAL ,combined detection on these multi-indicators have diagnostic value for Kawasaki disease combined with CAL.
3.Research on the Effect of Isodon Ternifolia-containing Serum on the Activation of Kupffer Cells Based on TLR4/NF-κB/NLRP3 Signal Pathway
ZHOU Zhipin ; CHEN Yong ; WU Ruisheng ; WANG Jingjing ; QIN Le ; HUANG Guidong ; LIU Daihua
Chinese Journal of Modern Applied Pharmacy 2023;40(21):2917-2925
Abstract
OBJECTIVE To investigate the effect of isodon ternifolia-containing serum(ITS) on the activation of rat primary hepatic Kupffer cell(KC) induced by lipopolysaccharide(LPS) through TLR4/NF-κB/NLRP3 signal pathway. METHODS The primary KC of rats were isolated and cultured, and the primary KC induced by LPS were divided into blank control group, model control group, blank serum group, positive control group(colchicine containing serum group), ITS group, TLR4 blocker group and TLR4 blocker+ITS group. MTT assay was used to detect the effect of different concentrations of ITS on the proliferation activity of KC. The content of interleukin-1β(IL-1β), interleukin-18(IL-18), tumor necrosis factor-α(TNF-α) and interleukin-6(IL-6) in KC supernatant were detected by ELISA. Fluorescence quantitative polymerase chain reaction(PCR), Western blotting and immunofluorescence were used to detect the expression of TLR4, nuclear factor κB inhibitor protein α(IκBα), cysteine protease-1(Caspase-1), NLRP3 mRNA and TLR4, IκBα, phosphorylated IκBα(p-IκBα), Caspase-1, NLRP3 and NF-κBp65 in KC. RESULTS Compared with the model control group, the contents of IL-1β, IL-18, TNF-α and IL-6 in the supernatant of KC and the expression of TLR4, IκB α, Caspase-1, NLRP3 mRNA and TLR4, IκBα, p-IκBα, Caspase-1, NLRP3, NF-κBp65 protein in the supernatant of KC in all drug groups were down-regulated or decreased(P<0.05 or P<0.01). Compared with TLR4 blocker group, the improvement of most of the above indexes in TLR4 blocker+ITS group was more obvious. CONCLUSION Isodon ternifolia may inhibit the activation of KC and reduce the expression and release of inflammatory factors by down-regulating TLR4/NF-κB/NLRP3 signal pathway, thus alleviating the inflammatory injury of liver.
4.Influence of prior percutaneous coronary intervention on outcome of coronary artery bypass grafting: A multi-center clinical study
Hongwei JIANG ; Hang ZHANG ; Wen CHEN ; Fangjing ZHENG ; Yongfeng SHAO ; Yongxiang QIAN ; Guoxiang WANG ; Mingqiu LI ; Qingsheng YOU ; Zhiyong LIU ; Yong WANG ; Zhenya SHEN ; Wei LI ; Demin LI ; Su HUANG ; Chongjun ZHONG ; Rui WANG ; Xin CHEN
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2022;29(11):1436-1441
Objective To investigate the influence of prior percutaneous coronary intervention (PCI) on the outcome of coronary artery bypass grafting (CABG). Methods Clinical data of 5 216 patients from Jiangsu Province CABG registry who underwent primary isolated CABG from 2016 to 2019 were retrospectively analyzed. Patients were divided into a PCI group (n=673) and a non-PCI group (n=4 543) according to whether they had received PCI treatment. The PCI group included 491 males and 182 females, aged 62.6±8.2 years, and the non-PCI group included 3 335 males and 1 208 females, aged 63.7±8.7 years. Multivariable logistic regression and propensity score matching (PSM) were used to compare 30-day mortality, incidence of major complications and 1-year follow-up outcomes between the two groups. Results Both in original cohort and matched cohort, there was no statistical difference in the 30-day mortality [14 (2.1%) vs. 77 (1.7%), P=0.579; 14 (2.1%) vs. 11 (1.6%), P=0.686], or the incidence of major complications (myocardial infarction, stroke, mechanical ventilation≥24 h, dialysis for new-onset renal failure, deep sternal wound infection and atrial fibrillation) (all P>0.05). The rate of reoperation for bleeding in the PCI group was higher than that in the non-PCI group [19 (2.8%) vs. 67 (1.5%), P=0.016; 19 (2.8%) vs. 7 (1.0%), P=0.029]. Both in original cohort and matched cohort, there was no statistical difference in 1-year survival rate between the two groups [613 (93.1%) vs. 4 225 (94.6%), P=0.119; 613 (93.1%) vs. 630 (95.2%), P=0.124], while the re-admission rate in the PCI group was significantly higher than that in the non-PCI group [32 (4.9%) vs. 113 (2.5%), P=0.001; 32 (4.9%) vs. 17 (2.6%), P=0.040]. Conclusion This study shows that a history of PCI treatment does not significantly increase the perioperative mortality and major complications of CABG, but increases the rate of cardiogenic re-admission 1 year postoperatively.
5.Role of penehyclidine in acute organophosphorus pesticide poisoning
Shi-yuan Yu ; Yan-xia Gao ; Joseph Walline ; Xin Lu ; Li-na Zhao ; Yuan-xu Huang ; Jiang Tao ; An-yong Yu ; Na Ta ; Ren-ju Xiao ; Yi Li
World Journal of Emergency Medicine 2020;11(1):37-47
BACKGROUND:
Penehyclidine is a newly developed anticholinergic agent. We aimed to investigate the role of penehyclidine in acute organophosphorus pesticide poisoning (OP) patients.
METHODS:
We searched the Pubmed, Cochrane library, EMBASE, Chinese National Knowledge Infrastructure (CNKI), Chinese Biomedical literature (CBM) and Wanfang databases. Randomized controlled trials (RCTs) recruiting acute OP patients were identified for meta-analysis. Main outcomesincluded cure rate, mortality rate, time to atropinization, time to 60% normal acetylcholinesterase (AchE) level, rate of intermediate syndrome (IMS) and rate of adverse drug reactions (ADR).
RESULTS:
Sixteen RCTs involving 1,334 patients were identified. Compared with the atropine-or penehyclidine-alone groups, atropine combined with penehyclidine significantly increased the cure rate (penehyclidine+atropine vs. atropine, 0.97 vs. 0.86, RR 1.13, 95% CI [1.07–1.19]; penehyclidine+atropine vs. penehyclidine, 0.93 vs. 0.80, RR 1.08, 95% CI [1.01–1.15]) and reduced the mortality rate (penehyclidine+atropine vs. atropine, 0.015 vs. 0.11, RR 0.17, 95% CI [0.06–0.49]; penehyclidine+atropine vs. penehyclidine, 0.13 vs. 0.08, RR 0.23, 95% CI [0.04–1.28]). Atropine combined with penehyclidine in OP patients also helped reduce the time to atropinization and AchE recovery, the rate of IMS and the rate of ADR. Compared with a single dose of atropine, a single dose of penehyclidine also significantly elevated the cure rate, reduced times to atropinization, AchE recovery, and rate of IMS.
CONCLUSION
Atropine combined with penehyclidine benefits OP patients by enhancing the cure rate, mortality rate, time to atropinization, AchE recovery, IMS rate, total ADR and duration of hospitalization. Penehyclidine combined with atropine is likely a better initial therapy for OP patients than atropine alone.
6.The immediate implant and immediate restoration in the anterior maxilla with the digital technique: case report and literature review
SHI Lei ; HUANG Sheng-Xing ; LIU Hui-Feng ; SUN Hai-Peng ; TANG Su ; GAO Yong-Bo
Journal of Prevention and Treatment for Stomatological Diseases 2017;25(2):119-122
Objective :
To describe a novel workflow for the anterior dental esthetics in immediate implant and immediate aesthetic restoration with digital technique.
Methods :
Before the implant placement, a intra-oral optical scan(IOS) combined with CBCT was performed to virtually design the 3D implant position and restoration. A surgical guide and an individualized Ti abutment restoration was CAD/CAM-fabricated out of the PMMA-based in a fully digital workflow and seated at the stage of minimal invasive surgery.
Results :
The technique achieved immediate implant and immediate restoration after tooth extraction. Immediate restoration of temporary crown could be completed immediately in second patient visit after the operation, finally realized the aesthetic implantation with preserved soft tissue contour.
Conclusin
The fully digital technique changed the conventional workflow which achieves more efficiency and better aesthetic effect.


Result Analysis
Print
Save
E-mail